Application Nr Approved Date Route Status External Links
NDA019445 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage 25% Dextrose Injection Is Indicated In The Treatment Of Acute Symptomatic Episodes Of Hypoglycemia In The Neonate Or Older Infant To Restore Depressed Blood Glucose Levels And Control Symptoms. Other Drugs, Such As Epinephrine And Glucagon, Should Be Considered In Patients Unresponsive Or Intolerant To Dextrose (Glucose). Oral Feeding Of Dextrose May Be Necessary In Infants With Frequently Recurring Hypoglycemic Episodes Or To Prevent Recurrences Due To Hyperinsulinemia. 25% Dextrose Injection Also Provides A Minimal Source Of Carbohydrate Calories.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dextrose Monohydrate

Comments